We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Oneok
OKE
$61B
| $239K | 0.08% |
+2,750
| New | +$242K |
2026 Q2
0 quarters
|
|
77
Sandisk
SNDK
$185B
| $227K | 0.08% |
+100
| New | +$143K |
2026 Q2
0 quarters
|
|
78
DELISTED
Webster Financial
WBS
| $223K | 0.07% |
2,914
+16
| +0.6% | +$1.16K |
2019 Q4
26 quarters
|
|
79
TriSalus Life Sciences
TLSI
$225M
| $220K | 0.07% |
48,300
+15,000
| +45% | +$59.6K |
2025 Q4
2 quarters
|
|
80
MiMedx Group
MDXG
$566M
| $215K | 0.07% |
55,878
| – | – |
2024 Q2
8 quarters
|
|
81
Viking Therapeutics
VKTX
$3.17B
| $207K | 0.07% |
5,310
| – | – |
2024 Q3
7 quarters
|
|
82
iShares S&P Small-Cap 600 Value ETF
IJS
$7.64B
| $207K | 0.07% |
1,512
+6
| +0.4% | +$774 |
2020 Q4
22 quarters
|
|
83
Fastenal
FAST
$60B
| $203K | 0.07% |
4,217
+1
| +0% | +$45 |
2019 Q4
26 quarters
|
|
84
Pliant Therapeutics
PLRX
$52.1M
| $189K | 0.06% |
166,224
| – | – |
2023 Q4
10 quarters
|
|
85
Best Buy
BBY
$20.9B
| $188K | 0.06% |
2,481
+39
| +2% | +$2.59K |
2019 Q4
26 quarters
|
|
86
Uber
UBER
$139B
| $185K | 0.06% |
2,558
-280
| -10% | -$20.5K |
2019 Q4
26 quarters
|
|
87
iShares MSCI EAFE ETF
EFA
$76.1B
| $181K | 0.06% |
1,744
+1
| +0.1% | +$103 |
2019 Q4
26 quarters
|
|
88
Solventum
SOLV
$14.7B
| $180K | 0.06% |
2,328
-68
| -3% | -$4.96K |
2024 Q2
8 quarters
|
|
89
Navitas Semiconductor
NVTS
$2.21B
| $179K | 0.06% |
10,000
| – | – |
2025 Q2
4 quarters
|
|
90
Cisco
CSCO
$418B
| $178K | 0.06% |
1,516
+11
| +0.7% | +$1.15K |
2019 Q4
26 quarters
|
|
91
Automatic Data Processing
ADP
$121B
| $177K | 0.06% |
792
| – | – |
2019 Q4
26 quarters
|
|
92
Sezzle
SEZL
$4.74B
| $172K | 0.06% |
+1,000
| New | +$105K |
2026 Q2
0 quarters
|
|
93
Lumentum
LITE
$70.3B
| $172K | 0.06% |
200
| – | – |
2025 Q2
4 quarters
|
|
94
Airbnb
ABNB
$103B
| $171K | 0.06% |
1,193
| – | – |
2021 Q1
21 quarters
|
|
95
Alibaba
BABA
$250B
| $168K | 0.06% |
1,754
-176
| -9% | -$22K |
2019 Q4
26 quarters
|
|
96
Ribbon Communications
RBBN
$245M
| $161K | 0.05% |
+69,000
| New | +$182K |
2026 Q2
0 quarters
|
|
97
Berkshire Hathaway Class B
BRK.B
$1.17T
| $156K | 0.05% |
311
| – | – |
2019 Q4
26 quarters
|
|
98
State Street Materials Select Sector SPDR ETF
XLB
$8.16B
| $155K | 0.05% |
3,044
| – | – |
2019 Q4
26 quarters
|
|
99
Marvell Technology
MRVL
$206B
| $153K | 0.05% |
514
+134
| +35% | +$26.9K |
2019 Q4
26 quarters
|
|
100
CrowdStrike
CRWD
$255B
| $153K | 0.05% |
800
-12
| -1% | -$1.7K |
2020 Q1
25 quarters
|
|
Similar funds
SIIL
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.